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Case. A right-handed 8-year-old female patient presented with a conventional, high-grade osteosarcoma involving her right
humerus; through-shoulder amputation was recommended. After consultation, total humerus resection with expandable, total
humeral endoprosthesis reconstruction was performed with a sleeve to encourage soft-tissue ingrowth. At three-year follow-up
she has received one lengthening procedure and her functional scores are excellent. Conclusion. Total humeral resection and
replacement in the pediatric population are rare and although early reports of expandable total humeral endoprosthesis outcomes
demonstrate high failure rates, this patient’s success indicates that expandable total humeral replacement is a viable option.

1. Introduction

2. Presentation of the Case

Osteosarcoma is the most common primary malignant tumor
of bone and most commonly affects children and young
adults in the second decade of life. Adjuvant chemotherapy
has improved the 5-year survival rate of nonmetastatic
osteosarcoma to approximately 70%. Subsequent advances
in three-dimensional radiological imaging and improved
implant technology have facilitated limb-preserving surgery
for osteosarcoma. Limb-preserving surgery in children
presents the additional challenge of accommodating growth.
We report the case of a pediatric patient diagnosed with
osteosarcoma of the right humerus. Prior to presentation to
our clinic, upper extremity amputation was recommended
for surgical management. After review of her radiographic
and staging studies and completion of her neoadjuvant
treatment, an expandable proximal humeral replacement
was performed. The purpose of this paper is to describe
her surgical management and three-year functional and
oncological outcome. The patient and her parents provided
consent for this study and her rights were protected.

A right-handed eight-year-old girl presented to her primary
care physician in Iowa with 2-3 weeks of right arm pain
at rest and with activity. There was no history of trauma
and she localized the pain to the proximal and midshaft
region of the right humerus. Radiographs revealed a blasticappearing lesion and referral to an orthopaedic oncology surgeon was undertaken. A core needle biopsy was performed
which confirmed a diagnosis of high-grade conventional
osteosarcoma. Staging studies were performed including a
computed tomography (CT) scan of the chest, magnetic
resonance imaging (MRI) of the humerus, and whole-body
Technetium-99 bone scan, which revealed no evidence of
metastatic disease or Enneking Stage IIB disease. Our patient
then began neoadjuvant chemotherapy and surgical planning
was undertaken for a through-shoulder amputation of the
right upper extremity. At this point her parents contacted our
clinic to discuss limb-preserving surgery.
Upon presentation to our clinic the patient had resolution
of her arm pain. She had no relevant medical, family, or social
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Figure 3: Surgical approach to the proximal humerus.

Figure 1: Anteroposterior radiograph of humerus following neoadjuvant chemotherapy for osteosarcoma.

Figure 4: Total humeral surgical specimen following dissection.

Figure 2: MRI of humerus demonstrating osteosarcoma lesion.

history. Physical examination revealed a well-appearing,
well-nourished, and interactive girl who appeared as her
stated age. Her right upper extremity showed increased girth
about the proximal and midshaft region of the humerus, a
well-healed biopsy incision, and no skin changes; the mass
was not tender to palpation. Her right arm showed normal
sensory, motor, and vascular function with full shoulder and
elbow motion compared to the left upper limb. The remainder
of her examination demonstrated no abnormalities.
Postchemotherapy radiographs showed mineralization
of her tumor (Figure 1); repeat chest CT and bone scan
demonstrated no evidence of metastatic disease. MRI showed
a mass occupying almost the entire humeral shaft (Figure 2).
Because local control of the tumor would require removal
of the entire humerus, a total humeral replacement was
recommended to the patient and her family. Due to the

patient’s young age and anticipated growth of 7.2 cm [1],
a reconstruction which could accommodate lengthening
was desired and therefore a custom, minimally invasive
lengthening total humeral endoprosthesis was designed and
built to her specifications by Stanmore (Stanmore Implants,
Elstree, UK). The device had a lengthening capacity of 8 cm.
Surgical resection of her tumor was performed through
an extensile anterior approach to the shoulder joint, anterolateral approach to the humeral shaft, and lateral approach to
the elbow joint (Figure 3). The brachialis muscle origin was
left on the specimen as it covered the soft-tissue mass and the
radial nerve was preserved (Figure 4). A custom, expandable
endoprosthesis was manufactured prior to surgery based on
measurements from preoperative imaging studies (Figure 5).
The rotator cuff was dissected free of the humerus at its insertion and preserved (Figure 6). Suture anchors were inserted
into the glenoid (Figure 7). A vascular graft was incorporated
into the anchor sutures (Gore Industries, Flagstaff, AZ, USA)
(Figure 8). The vascular graft was imbricated about the endoprosthesis with a fenestration to accommodate lengthening
mechanism access (Figure 9). The humeral musculature was
sewn to the vascular graft to encourage soft-tissue ingrowth.
The ulnar component was cemented. The incision was then
closed in layers without a drain and she was placed in
a splint. At the conclusion of the operation, motor and
sensory function was complete. Postoperative radiographs
showed the implant to be in good position (Figure 10). In
the postoperative period shoulder motion was restricted
in an effort to encourage rotator cuff ingrowth into the
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Figure 5: Total humeral surgical specimen and expandable total
humeral endoprosthesis.
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Figure 9: Endoprosthesis following ulnar cementation, suturing of
rotator cuff to vascular graft, and imbrication of the vascular graft
with nonabsorbable sutures.

Figure 6: Preserved rotator cuff and shoulder joint capsule marked
with tag sutures.

Figure 10: Postoperative anteroposterior humeral radiograph with
implanted endoprosthesis.

Figure 7: Placement of suture anchors about glenoid neck.

Figure 8: Vascular graft being positioned over glenoid prior to
placement of endoprosthesis.

vascular graft. Postoperative physical therapy was begun six
weeks after surgery beginning with passive shoulder motion,
gradually transitioning to active shoulder motion after three
months.
At present our patient is three years from surgery and
remains without evidence of local or distant disease progression. She has undergone one lengthening operation with
a total of 0.7 cm of expansion. Her shoulder demonstrates
passive abduction and flexion of 0–120 and 0–135, respectively. Active shoulder abduction and flexion are 0–110 and
0–130, respectively. Shoulder strength in both abduction and
flexion are 4/5; strength with internal and external rotation
is 2+/5. Active and passive elbow motion are 0–125 with
strength of 3/5 in flexion and 4/5 in extension. She was able
to resume playing the piano without difficulty or discomfort.
Adolescent PODCI self-reported global mean and normative
scores were 92 and 46; adolescent PODCI parent-reported
global mean and global normative scores were 95 and 50,
respectively; PODCI domain scores are reported in Table 1.
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Table 1: PODCI domain scores.
Upper extremity
(m)
(n)

Mobility
(m)
(n)

Domain
Sports
Pain
(m)
(n)
(m)
(n)

Happiness
(m)
(n)

Global
(m)
(n)

92
96

100
100

82
85

95
95

92
95

Self-reported
Parent-reported

34
44

52
52

39
42

93
100

53
57

57
57

46
57

(m): mean; (n): normative.

Table 2: Literature summary for expandable total humerus replacements.
Authors
Lavy and Briggs [27]
Unwin and Walker [19]
Ayoub et al.
Eckardt et al. [11]
Young et al.
Natarajan et al.
Puri, Gulia

Year
1992
1996
1999
2000
2011
2011
2012

Implants
3
7
6
5
1
2
2

Surviving patients
3
NA
2
NA
1
2
1

Failures
3
1
0∗
NA
0
1
1

Failure modes (n)
1 (2); 4 (1)
4 (1)
0∗
NA
5 (1)
3 (1)

Failure modes: 1: soft tissue; 2: aseptic loosening; 3: structural; 4: infection; 5: disease recurrence. ∗ One patient had a forequarter amputation for pain unrelated
to the prosthesis.

3. Discussion
The goal of limb-sparing surgery for connective tissue cancers
is complete tumor excision leading to disease-free survival
with a functional limb [2]. While limb salvage techniques
have evolved substantially over the last fifty years and
oncological results are comparable to amputation, the goal
of complete restoration of function has not been realized
and surgical complications remain significantly higher than
comparable primary total joint arthroplasty procedures [3].
Endoprosthesis reconstructions with uniaxial and
polyaxial articulations are affected by different failure modes;
uniaxial articulations are frequently subject to aseptic
loosening and polyaxial joints are commonly unstable [3].
Total humeral reconstructions are subject to failure modes
relevant to both joint types and have higher failure rates than
either proximal or distal humeral replacements [3].
Because the preponderance of pediatric primary malignant bone tumors occurs about the knee and hip, expandable
implants were first described for use in the lower extremity
by Scales et al. in 1976 [4]. Since that time, numerous authors
have published small series reporting generally favorable
patient outcomes for lower extremity expandable implants
[5–24]. In addition to conventional modes of failure [3],
expandable implants are vulnerable to problems of lengthening mechanism failure and adjacent physeal injury [24–26].
Use of expandable endoprostheses in the upper extremity
is far less common than in the lower extremity, due to both
the distribution of pediatric bone cancers and the difficulty
of creating a lengthening mechanism that fits neatly into a
pediatric humerus-sized package. An expandable humerus
implant was first conceived in 1985 by the Biomechanical
Engineering Department at the Royal National Orthopaedic
Hospital at Stanmore. Lavy and Briggs reported on the use of
the Stanmore implant for total humerus replacement and the

results were poor with all three implants resulting in failure
[27]. According to our literature review, expandable total
humeral replacement has been attempted an additional 23
times, with over one-half of surviving patients experiencing
failure of their device (Table 2). While these results suggest
an abysmal forecast for patients receiving an expandable total
humeral replacement, it should be noted that 21 of these
patients underwent surgery in the 1980s and 1990s, when
endoprosthesis design and use were still in their earliest
phase. Although still a nascent technology, early failures have
led to improved understanding of the mechanical challenges
facing these reconstructions and will likely lead to improved
outcomes as results of newer implants are reported. The
authors believe the patient described here has obtained good
shoulder function through a combination of the patient’s
young age and meticulous reconstruction of the rotator cuff
using a porous in-growth surface.
To our knowledge the case presented here is the seventh
expandable total humerus replacement performed in the US
and is the first to combine the Stanmore minimally invasive
lengthening implant with a porous sleeve for soft tissue
ingrowth. Current technology does not allow for noninvasive
lengthening; however, this will likely be available in the
future. Revision of the current prosthesis is not mandatory
and will be undertaken only in the event of failure. Based on
the excellent oncological and functional results of our patient,
and the antithetical alternative of upper extremity amputation, we believe that expandable total humeral replacement
is an excellent option for the skeletally immature patient
meeting indications.
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